2022 Synapse Faculty
synapse_home
faculty icon

Faculty

CHAIRMAN

Andrew J. Cutler, MD


Chief Medical Officer, Neuroscience Education Institute, Carlsbad, CA

Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY


Dr. Andrew J. Cutler attended Haverford College in Philadelphia, Pennsylvania, earning a BS in Biology.  He received his MD from the University of Virginia School of Medicine, where he was also elected to the Alpha Omega Alpha (AOA) honor medical society and received the Merck Award for outstanding medical scholarship. He completed his Medical internship, Internal Medicine residency and Psychiatry residency at the University of Virginia Medical Center, where he served as Chief Resident of Psychiatric Medicine and did research on dopamine receptor pharmacology in the lab of James P. Bennett, MD, PhD.  Dr. Cutler then served as the first Assistant Professor and Director of Psychiatric Medicine at the University of Chicago.  He has been Board Certified in both Internal Medicine and Psychiatry.

Dr. Cutler has been Principal Investigator (PI) on over 400 psychiatric and medical clinical trials.  

Dr. Cutler has authored over 50 peer-reviewed scientific articles and has authored and presented over 100 abstracts/posters at various scientific meetings.  He serves as a peer reviewer for many prestigious scientific and medical journals and serves or has served on several Editorial Boards.  He has chaired or attended over 200 Scientific Advisory Boards, delivered over 3,000 pharmaceutical promotional talks and over 250 invited CME lectures and Grand Rounds presentations.  He has also done over 30 national satellite television medical education broadcasts and over 100 national medical web conferences.

Dr. Cutler is a member of several professional organizations, including the American Psychiatric Association, the Florida Psychiatric Society and the American Medical Association.  He has earned the Certified Physician Investigator (CPI) distinction from the Academy of Physicians in Clinical Research (formerly the Academy of Pharmaceutical Physicians and Investigators). He is a Fellow of the American Psychiatric Association and the Academy of Psychosomatic Medicine. He has received several professional honors and awards including the Merck Award for outstanding medical scholarship, the University of Virginia Pride Award for outstanding patient care, the William Sorum Award from the American Psychiatric Association, the Outstanding Congressional Fellow Award from the 103rd U.S. Congress, a citation from Florida Hospital for outstanding patient care and the Distinguished Clinical Professional Award from the Mental Health Association of Central Florida. He presents research posters and teaches at professional meetings and has published numerous articles in scientific and medical journals. Dr. Cutler frequently gives talks to community groups and national audiences, and often appears as a medical expert in the local and national media. 

read more +




Deborah Butturini


Mother, Suicide Loss

Director, Account Management—Key Accounts, Express Scripts, Fairfield, OH


Deborah is an Operation's Director, with a focus on people and team leadership. She has been employed with the same large Health Systems company for the last 25 years. She works using an enterprise mindset to deliver predictable, affordable, simple health care.

Located in Cincinnati, Ohio, Deborah is an advocate and volunteer for Mental Health, Suicide Prevention and Grief resources. 

read more +




Leslie Citrome, MD, MPH


Clinical Professor, Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY


Dr. Leslie Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is the Editor-in-Chief of the International Journal of Clinical Practice, published by Wiley. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation.

Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm.

Dr. Citrome is the author or co-author of over 400 research reports, reviews, and chapters in the scientific literature, is on the editorial board of 13 different medical journals, reviews for over 90 journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.

read more +




David W. Goodman, MD, FAPA


Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD

Director and Founder, Adult Attention Deficit Disorder Center of Maryland, Baltimore, MD


Dr. David W. Goodman is an assistant professor in the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine in Baltimore, and the director and founder of the Adult Attention Deficit Disorder Center of Maryland in Baltimore, MD. His interests include adult ADHD, associated mood/anxiety/substance use disorders, and complex psychopharmacology. 

read more +




Mary C. Kimmel, MD


Assistant Professor; Co-Director, Perinatal Psychiatry Program; Medical Director, NC Maternal Mental Health MATTERS Program; University of North Carolina School of Medicine, Chapel Hill, NC


Dr. Kimmel was the medical director for five years for the UNC’s Perinatal Psychiatry Inpatient Unit, the first unit of its kind in the United States to provide inpatient psychiatric care to pregnant and postpartum women, providing care to individuals with treatment resistant depression, OCD, and postpartum psychosis. The NC Maternal Mental Health MATTERS program provides education and support to frontline providers in the care of their pregnant and postpartum patients through screening, assessment and treatment of stress, anxiety, depression, and other behavioral health disorders. Dr. Kimmel’s research is focused on the microbiota-gut-brain axis and stress reactivity across pregnancy and the postpartum period and in relation to the development of maternal depression and anxiety and the child’s development.  Specific focus is on heart rate variability as it represents the Autonomic Nervous System, immune system markers, and the microbiome as a marker of the host-environment interface.  The NIMH, HRSA, Brain & Behavior Research Foundation and the Foundation of Hope funding support Dr. Kimmel’s work.

read more +




Carmen Kosicek, MSN, APNP, PMHNP-BC


CEO, Founder, and Provider, Alay Health Team, Medford, OR


Although she first started in Nuclear Medicine, Carmen returned to school with a focus in nursing.  She went on in her studies and graduated in 1998 from Case Western Reserve University with her MSN, and later, with her first post graduate nurse practitioner focus certification as a Nurse Midwife was from Frontier University.  Nearly 20 years later, she again returned to graduate school and in 2016, she earned her second post graduate nurse practitioner certification as a Psychiatric Mental Health Nurse Practitioner from the University of Cincinnati.

In 2017, Carmen started her own company, which now spans three states, 9+ providers and 6,000 patients. She is a pioneer in the telepsychiatry world as from the beginning, tele services were offered by her company in the outpatient rural settings that she primarily serves.  Alay Health Team, Carmen's company that she founded and runs, serves children through adults, even in group homes, County facilities, and immediately post discharge for patients from prison systems.  From SMI to addiction, a full scope of psychiatric services is what Carmen and her team treat, primarily in rural markets.

Carmen and her team of PMHNPs accept graduate PMHNP-clinical resident students from over 45 different universities across the US and as such, Alay Health Team is the largest teaching facility for PMHNP-clinical residents via tele psych in the country.  Over 500 PMHNPs have come to learn not only tele psychiatry, but the implementation and utilization of evidenced based practice with the newer pharmaceutical therapies in the marketplace.  Fiscal obtainability is additionally taught with the nuances required to fulfill these new meds.

Carmen has been expanding her reach of teaching and PMHNP placement to a multi-site primary care provider company by imbedding psychiatric services into primary care offices as the Executive Director of Behavioral Health Services.  The progressive psychiatric prescribing that Carmen is known for, continues to expand as her previous clinical residents have now become her colleagues across the companies that she places these progressive providers in and continues to orchestrate further development of these new providers during their first few formative years.

read more +




Roger S. McIntyre, MD, FRCPC


Professor, Departments of Psychiatry and of Pharmacology; Head, Mood Disorders Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
Professor, Guangzhou Medical University, Guangzhou, China
Professor, College of Medicine, Korea University, Seoul, Republic of Korea,
Professor, State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA
Professor, University of California School of Medicine, Riverside, California, USA
Chairman and Executive Director, Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada
Director and Chair, Scientific Advisory Board, Depression and Bipolar Support Alliance (DBSA), Chicago, Illinois, USA


Dr. Roger S. McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. 

Dr. McIntyre was named by Thomson Reuters in 2014 and 2015, as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.    

Dr. McIntyre is involved in multiple research endeavors which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment. 

Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.

Dr. McIntyre is a contributor to the “Florida Medicaid Drug Therapy Management Program for Behavioral Health: Guidelines for the treatment of adults with Major Depressive Disorder and Bipolar Disorder”. Dr. McIntyre is also the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the “CANMAT Guidelines for the Treatment of Depressive Disorders and Bipolar Disorders”. Dr. McIntyre has published hundreds of peer-reviewed articles and has edited and/or co-edited several textbooks on mood disorders.

Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

read more +




Jonathan M. Meyer, MD


Clinical Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA


Dr. Jonathan M. Meyer is a graduate of Stanford University and Harvard Medical School and finished his adult psychiatry residency at Los Angeles County-USC Medical Center. At LA County-USC he subsequently completed fellowships in Consultation/Liaison Psychiatry and Psychopharmacology Research.

In addition to teaching duties at UC San Diego, Dr. Meyer has performed extensive research on the metabolic effects of antipsychotics, and the impact of antipsychotic medications on glucose-insulin homeostasis. Dr. Meyer has published numerous articles and book chapters on various aspects of antipsychotic psychopharmacology including the pharmacokinetics of oral and depot antipsychotics, metabolic effects of atypical antipsychotics, as well as on the health care outcomes in patients with severe mental illness. Dr. Meyer is a national speaker on the subject of side effects and metabolic issues surrounding antipsychotic therapy, is chief editor of Medical Illness and Schizophrenia, now in its 2nd edition, and is the sole author of the chapter on the “Pharmacotherapy of Psychosis and Mania” in the last two editions of Goodman & Gilman's The Pharmacological Basis of Therapeutics.

read more +




Christine Moutier, MD


Chief Medical Officer, American Foundation for Suicide Prevention, New York, NY

Clinical Professor, Department of Psychiatry, Columbia University, New York City, NY



Dr. Christine Yu Moutier knows the impact of suicide firsthand. After losing colleagues to suicide, she dedicated herself to fighting this leading cause of death. As a leader in the field of suicide prevention, Dr. Moutier joined AFSP as Chief Medical Officer in 2013, and it’s through her passion and commitment that we see a lasting impact via research, education and support to communities across the U.S.

She has testified before the U.S. Congress and provided multiple Congressional briefings on suicide prevention. She has presented to the White House and at the National Academy of Sciences, she co-anchored CNN’s Emmy Award winning Finding Hope suicide prevention town hall, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, the BBC, CNN, NBC and other print and television outlets.

Since earning her medical degree and training in psychiatry at the University of California, San Diego, Moutier has been a practicing psychiatrist, professor of psychiatry, dean in the medical school, and medical director of the Inpatient Psychiatric Unit at the VA Medical Center in La Jolla, treating diverse patient populations from Asian refugees to veterans to corporate and academic leaders. Dr. Moutier has authored a clinical suicide prevention handbook which released in 2021, and numerous articles and book chapters for medical and general audiences. Most recently, co-led a partnership effort with the American Academy of Pediatrics (AAP), AFSP and NIMH to establish a new National Blueprint for Youth Suicide Prevention, being released in early 2022.   

read more +




Donna Rolin, PhD, APRN, PMHCNS-BC, PMHNP-BC


Director Psychiatric Mental Health Nurse Practitioner Program, Clinical Associate Professor, The University of Texas at Austin School of Nursing, Austin, TX

Psychiatric Advanced Practice Registered Nurse, Greater Austin Psychiatry & Wellness, Austin, TX

Psychiatric Advanced Practice Registered Nurse, Psychiatric Associates of Central Texas / Gero-Psychiatric Associates, Austin, TX



Dr. Donna Rolin received her PhD in Nursing Research from New York University and MSN in Psychiatric Nursing from the University of Pennsylvania. Her research focuses on mental health promotion, community psychiatry, and addiction. She is active in the American Psychiatric Nurses Association, where she recently served on the national Board of Directors for five years as Treasurer and locally in the Psychiatric Advanced Practice Nurses of Austin organization in the role of president.

Her clinical PMH-APRN background encompasses CBT, group, and family psychotherapy, psychiatric evaluation, and pharmacotherapy for persons with mental illness in inpatient, outpatient, community, and forensic settings. Currently, she practices in a community-based group working with underserved patients with serious mental illness and intellectual/developmental disabilities. She consults with the American Psychiatric Association on an educational collaborative on serious mental illness. Dr. Rolin became Nursing Co-Director of the Institute on Domestic Violence and Sexual Assault (IDVSA) in 2017. She collaborates with UT Schools of Medicine, Psychology, Social Work, and Pharmacy on training grants for integrated graduate clinical training.

Dr. Rolinʼs recent national and regional professional conference presentations include psychopharmacology (clozapine and long-acting injectable antipsychotic medications), measurement-based care, promotion of psychotherapy for PMHNPs, and clinician burnout. She and colleagues launched several wellness intervention research studies aimed to improve mental health outcomes such as depression, anxiety, disability, sleep, and wellness in various populations and settings.   

read more +




Thomas L. Schwartz, MD


Professor and Chair, Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY


Dr. Thomas L. Schwartz is active on many teaching, administrative and curriculum committees at SUNY, he also provides direct resident supervision, lectures in several courses, and directs and organizes continuing medical education events for the psychiatry department.

Dr. Schwartz received his medical degree from and completed his residency in adult psychiatry at the State University of New York (SUNY) Upstate Medical University in Syracuse, New York.

Dr. Schwartz’s abilities as a medical educator have been recognized with the Marc H. Hollander, MD, Psychiatry Award, Teacher of the Year, and Mentor of the Year awards from SUNY Upstate Medical University; Nancy Roeske, MD, Irma Bland, Certificates of Recognition for Excellence in Medical Student and Resident Education from the American Psychiatric Association, the SUNY Upstate President’s and the SUNY Chancellor’s Award for Teaching.   

Dr. Schwartz is the author of Practical Psychopharmacology: Basic to Advanced Principles, "Stahl’s Essential Psychopharmacology” Case Studies Volume 2, Integrating Psychotherapy and Pharmacotherapy, Antipsychotic Drugs: Pharmacology, Side Effects and Abuse Prevention, Second and Third Generation Antipsychotics.  He is the editor of Depression: Treatment Strategies and Management, 1st and 2nd Eds. and is the Deputy Editor for the journal CNS Spectrums.

read more +




Stephen M. Stahl, MD, PhD, DSc (Hon.)


Clinical Professor, Department of Psychiatry and Neuroscience, University of California, Riverside School of Medicine, Riverside, CA
Adjunct Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA
Honorary Visiting Senior Fellow, University of Cambridge, Cambridge, UK 
Editor-in-Chief, CNS Spectrums
Director of Psychopharmacology Services, California Department of State Hospitals, Sacramento, CA


Dr. Stephen M. Stahl received his undergraduate and medical degrees from Northwestern University in Chicago, as a member of the Honors Program in Medical Education, and his Ph.D. degree in pharmacology and physiology from the University of Chicago. Dr. Stahl has trained in three specialties: internal medicine at the University of Chicago; neurology at the University of California in San Francisco; and psychiatry at Stanford University. He is board certified in psychiatry.  

Dr. Stahl has held faculty positions at Stanford University, the University of California at Los Angeles (UCLA), the Institute of Psychiatry London, the Institute of Neurology London, and, currently, as professor at the University of California at San Diego (UCSD) and as an Honorary Visiting Senior Fellow in the Department of Psychiatry at the University of Cambridge in the UK. He also directs psychopharmacology services and academic programs for the eight-facility, 6500 patient California Department of State Hospital System, where he also heads their assessment and treatment efforts to reduce violence. Dr. Stahl was formerly Executive Director of Clinical Neurosciences at the Merck Neuroscience Research Center in the UK for several years. Dr. Stahl’s major interests are dedicated to producing and disseminating educational information about diseases and their treatments in psychiatry and neurology, with a special emphasis on multimedia, the internet and teaching how to teach.  

Dr. Stahl currently serves as editor-in-chief of CNS Spectrums. He is also past associate editor of Acta Psychiatrica Scandinavica, former clinical field editor for the International Journal of Neuropsychopharmacology and is currently on numerous editorial boards of other leading journals including the ACNP’s journal Neuropsychopharmacology. He has conducted numerous research projects during his career awarded by the National Institute of Mental Health (NIMH), by the Department of Veteran Affairs (VA) and by the pharmaceutical industry. Author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, Dr. Stahl is an internationally renowned clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has written 35 books and edited 12 others, including the best-selling and award-winning textbook, Stahl’s Essential Psychopharmacology, now in its fourth edition, the best-selling and award winning clinical manual, Essential Psychopharmacology Prescriber’s Guide, now in its sixth edition.  

Lectures, courses and preceptorships based upon his textbooks have taken him to dozens of countries on 6 continents to speak to tens of thousands of physicians, mental health professionals and students at all levels. His lectures and scientific presentations have been distributed as more than a million CD-ROMs, internet educational programs, videotapes, audiotapes and programmed home study texts for continuing medical education to hundreds of thousands of professionals in many different languages. His courses and award-winning multimedia teaching materials are used by psychopharmacology teachers and students throughout the world.  

Dr. Stahl serves as a fellow of the ACNP (American College of Neuro-psychopharmacology), of the British Association of Psychopharmacology (BAP) and of the CINP, where he was formerly vice president and is a Distinguished Life Fellow of the American Psychiatric Association (APA). He also has served on numerous medical and scientific advisory boards for the pharmaceutical industry, for the biotechnology and medical information industry, and for various nonprofit and public service organizations, including appointment by the State of California and past Chair of the Medi-Cal Oversight Board for Medicines (Drug Utilization Review Board).

His educational research programs are monitoring changes in diagnosing and prescribing behaviors as outcomes from various educational interventions for programs organized by the Neuroscience Education Institute, which he chairs. He also has an active clinical practice specializing in psychopharmacologic treatment of resistant cases.

He has been awarded the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education for his contributions to postgraduate education in psychiatry and neurology. His books have won the British Medical Association’s Book of the Year Award and Arbor Scientia has been awarded the business of the year award from the local chamber of commerce. Dr. Stahl is also the winner of the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, the UCSD department of psychiatry residency teaching award, and has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America.” He was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecture for 2013. Recently, his alma mater Northwestern University honored him by naming their annual award for the best medical student going into psychiatry the Stephen Stahl award. Dr. Stahl was named the 2016 David A Mrazek Memorial Award Winner by the American Psychiatric Association and delivered the Mrazek Lecture at the annual meeting of the APA.

read more +